Replies to post #66261 on Biotech Values

[DewDiligence]

MNTA – From the 2Q08 CC transcript (#msg-31026200):

>>
Earlier in July, Teva and Amphastar were granted an extension until August 21st to file a response to the Sanofi-Aventis petition for rehearing. Furthermore, several parties, including Pharma and Bio, have filed amicus briefs in support of the petition for a rehearing. All of these actions are extending the period of time it will take for the court of appeals to consider the petition. Historic data suggests courts typically rule on a rehearing request within one to two months after the briefs are submitted. But there is no required timeline on the court.
<<

[DewDiligence]

>MNTA – I would also note that news is due any day regarding the supplemental submission to the FDA.<

Yes—Craig Wheeler said on the MS webcast last week that Sandoz/MNTA were putting the finishing touches on the response letter.

[DewDiligence]

MNTA is presenting at the UBS conference one week from today:

http://biz.yahoo.com/pz/080916/150469.html